CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

Clinical trial NCT04450069 · COMPLETED

Trial details

NCT number: NCT04450069
Sponsor: Calibr, a division of Scripps Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory B-cell Lymphomas Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Chronic Lymphocytic Leukemia (CLL)Marginal Zone Lymphoma (MZL)Mantle Cell Lymphoma Small Lymphocytic Lymphoma (SLL)Primary Mediastinal Large B Cell Lymphoma Transformed Follicular Lymphoma Waldenstrom Macroglobulinemia Lymphoplasmacytic Lymphoma Burkitt Lymphoma

Start date: 2020-08-14
Primary completion: 2024-05-06
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.